However, recentexciting clinical findings with a dual-acting GLP-1 and GIP receptor hybridpeptide exhibiting strong bias towards the GIP receptor,36 suggests that GIP resistance in type 2 diabetes is surmountable. Here, GIP is linked to type 2 diabetes mellitus.